THE DEPENDENCE OF TRANSLOCATOR PROTEIN TSPO LEVEL AND CYTOCHROME P450SCC FROM HISTOTYPE OF TUMOR IN PATIENTS WITH RENAL CELL CARCINOMA
Abstract
The features of expression of translocator protein (TSPO) and cytochrome P450scc (CYP 450scc) in patients with renal cell carcinoma (RCC) were described in the article. The dependence of level expression of TSPO from stage and histological subtypes of renal cell carcinoma were established. The changing of expression level of CYP 450scc in tumor cells indicates a change of severity of steroidogenesis in different histological subtypes of RCC. These findings were important for interpretation the pathogenesis of RCC and also they could have prognostic value
About the Authors
R. A. Zukov
V.F. Voino-Yasenetsky Krasnoyarsk State Medical University
Russian Federation
Russian Federation
T. G. Ruksha
V.F. Voino-Yasenetsky Krasnoyarsk State Medical University
Russian Federation
Russian Federation
Yu. A. Dykhno
V.F. Voino-Yasenetsky Krasnoyarsk State Medical University
Russian Federation
Russian Federation
E. V. Semenov
V.F. Voino-Yasenetsky Krasnoyarsk State Medical University
Russian Federation
Russian Federation
N. V. Boyakova
V.F. Voino-Yasenetsky Krasnoyarsk State Medical University
Russian Federation
Russian Federation
References
1. Гырылова С.Н., Комина А.В., Рукша Т.Г. Индукция апоптоза клеток меланомы лигандом TsPO РК11195 // Сибирский онкологический журнал. 2011. № 1 (43). С. 40–43.
2. Alana M., Kassiou S., Kassiou M. The translocator protein // J. Nucl. Med. 2011. Vol. 52. P. 677–680.
3. Batarseh A., Li J., Papadopoulos V. Protein kinase C epsilon regulation of translocator protein (18 kDa) Tspo gene expression is mediated through a MAPK pathway targeting STAT3 and c-Jun transcription factors // Biochemistry. 2010. Vol. 49. P. 4766–4778.
4. Batarseh A., Papadopoulos V. Regulation of translocator protein 18kDa (TSPO) expression in health and disease states // Mol. Cell. Endocrinol. 2010. Vol. 327. P. 1–12.
5. Cheville J.C., Lohse C.M., Zincke H. et al. Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma // Amer. J. Surg. Pathol. 2003. Vol. 27. P. 612–624.
6. Dalla Valle L., Toffolo V., Vianello S. et al. Expression of cytochrome P450scc mRNA and protein in the rat kidney from birth to adulthood // J. Steroid Biochem. Mol. Biol. 2004. Vol. 88. P. 79–89.
7. Fafalios A., Akhavan A., Parwani A.V. et al. Translocator protein blockade reduces prostate tumor growth // Clin. Cancer Res. 2009. Vol. 15. P. 61–77.
8. Galiègue S., Casellas P., Kramar A. et al. Immunohistochemical assessment of the peripheral benzodiazepine receptor in breast cancer and its relationship with survival // Clin. Cancer Res. 2004. Vol. 10. P. 2058–2064.
9. Han Z., Slack R.S., Li W., Papadopoulos V. Expression of peripheral benzodiazepine receptor (PBR) in human tumors: relationship to breast, colorectal, and prostate tumor progression // J. Recept. Signal Transduct. Res. 2003. Vol. 23. P. 225–238.
10. Hardwick M., Fertikh D., Culty M. et al. Peripheral-type benzodiazepine receptor (PBR) in human breast cancer: correlation of breast cancer cell aggressive phenotype with PBR expression, nuclear localization, and PBR-mediated cell proliferation and nuclear transport of cholesterol // Cancer Res. 1999. Vol. 59. P. 831–842.
11. Kabat C.C., Etgen A.M., Rohan T.E. Do steroid hormones play a role in the etiology of glioma? // Cancer Epidemiol. Biomarkers Prev. 2010. Vol. 19. P. 2421–2427.
12. Li W., Hardwick M.J., Rosenthal D. et al. Peripheral-type benzodiazepine receptor overexpression and knockdown in human breast cancer cells indicate its prominent role in tumor cell proliferation // Biochem. Pharmacol. 2007. Vol. 73. P. 491–503.
13. Maaser K., Hopfner M., Jansen A. et al. Specific ligands of the peripheral benzodiazepine receptor induce apoptosis and cell cycle arrest in human colorectal cancer cells // Br. J. Cancer. 2001. Vol. 85. P. 1771–1780.
14. Molina A.M., Tickoo S.K., Ishill N. et al. Sarcomatoid-variant renal cell carcinoma: treatment outcome and survival in advanced disease // Am. J. Clin. Oncol. 2011. Vol. 34 (5). P. 454–459.
15. Mukherjee S., Das S.K. Translocator protein (TSPO) in breast cancer // Curr. Mol. Med. 2012. Vol. 12. P. 443–457.
16. Patard J.-J., Leray E., Rioux-Leclercq N. et al. Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience // J. Clin. Oncol. 2005. Vol. 23. P. 2763–2771.
17. Simpson E.R., Waterman M.R. Regulation by ACTH of steroid hormone biosynthesis in the adrenal cortex // Can. J. Biochem. Cell. Biol. 1983. Vol. 61. P. 692–707.
18. Veenman L., Papadopoulos V., Gavish M. Channel-Like Functions of the 18-kDa Translocator Protein (TSPO): Regulation of Apoptosis and Steroidogenesis as Part of the Host-Defense Response // Curr. Pharm. Des. 2007. Vol. 13. P. 2385–2405.
Review
For citations:
Zukov R.A., Ruksha T.G., Dykhno Yu.A., Semenov E.V., Boyakova N.V. THE DEPENDENCE OF TRANSLOCATOR PROTEIN TSPO LEVEL AND CYTOCHROME P450SCC FROM HISTOTYPE OF TUMOR IN PATIENTS WITH RENAL CELL CARCINOMA. Siberian journal of oncology. 2013;(3):47-51. (In Russ.)
Views:
434
Email this article 
